Uncategorized
Epimacular brachytherapy with anti-VEGF not superior to anti-VEGF monotherapy for wet AMD
Macular epiretinal brachytherapy combined with ranibizumab did not reduce the number of ranibizumab injections that patients required for the treatment of neovascular age-related macular degeneration, according to a study.Principal investigator Tim Jackson, PhD, FRCOphth, outlined results of the MERLOT study at the Euretina meeting in Barcelona, Spain.